ArticleThe EPMA journal2022

Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients.

Julia Brunmair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.